{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:47:55Z","timestamp":1790948875728,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.acra.2025.07.034","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T14:49:16Z","timestamp":1754405356000},"page":"6823-6839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Beyond Cancer: The Role of Radiolabeled Fibroblast Activation Protein Inhibitors (FAPI) in Non-Oncological Molecular Imaging"],"prefix":"10.1016","volume":"32","author":[{"given":"Esmail","family":"Jafari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik E.","family":"Juweid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrzad","family":"Bahtouee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Pourbehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komeil","family":"Esmaeilinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges","family":"Jokar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Assadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.acra.2025.07.034_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ph17030296","article-title":"Molecular imaging of fibrosis in benign diseases: an overview of the state of the art","volume":"17","author":"Zhang","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.acra.2025.07.034_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ph17060716","article-title":"The role of fibroblast activation protein inhibitor positron emission tomography in inflammatory and infectious diseases: an updated systematic review","volume":"17","author":"Albano","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.acra.2025.07.034_bib3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2478\/rir-2024-0021","article-title":"Fibroblast activation protein inhibitor PET\/CT as an emerging diagnostic modality in interstitial lung disease and other fibrotic conditions","volume":"5","author":"Albu","year":"2024","journal-title":"Rheumatol Immunol Res"},{"issue":"19","key":"10.1016\/j.acra.2025.07.034_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13194946","article-title":"FAP and FAPI-PET\/CT malignant and non-malignant diseases: a perfect symbiosis?","volume":"13","author":"Dendl","year":"2021","journal-title":"Cancers"},{"issue":"1142","key":"10.1016\/j.acra.2025.07.034_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1259\/bjr.20220463","article-title":"Non-oncologic incidental uptake on FAPI PET\/ CT imaging","volume":"96","author":"Hotta","year":"2023","journal-title":"Br J Radiol"},{"issue":"12","key":"10.1016\/j.acra.2025.07.034_bib6","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2967\/jnumed.122.264205","article-title":"Fibroblast activation protein inhibitor imaging in nonmalignant diseases: a new perspective for molecular imaging","volume":"63","author":"Schmidkonz","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.acra.2025.07.034_bib7","doi-asserted-by":"crossref","DOI":"10.1053\/j.semnuclmed.2025.04.003","article-title":"Targets for molecular imaging of neuroendocrine tumors (NETs): an overview and update","author":"Jafari","year":"2025","journal-title":"Semin Nucl Med"},{"issue":"18","key":"10.1016\/j.acra.2025.07.034_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12186033","article-title":"Highlighting fibroblasts activation in fibrosis: the state-of-the-art fibroblast activation protein inhibitor PET imaging in cardiovascular diseases","volume":"12","author":"Cui","year":"2023","journal-title":"J Clin Med"},{"issue":"July","key":"10.1016\/j.acra.2025.07.034_bib9","article-title":"Gallium-68 fibroblast activation protein inhibitor positron emission tomography in cardiovascular disease","volume":"3","author":"Mpanya","year":"2023","journal-title":"Front Nucl Med"},{"issue":"5","key":"10.1016\/j.acra.2025.07.034_bib10","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/path.4481","article-title":"Sustained \u03b2-catenin activity in dermal fibroblasts promotes fibrosis by up-regulating expression of extracellular matrix protein-coding genes","volume":"235","author":"Hamburg-Shields","year":"2015","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.acra.2025.07.034_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/JCI71386","article-title":"Fibrotic extracellular matrix activates a profibrotic positive feedback loop","volume":"124","author":"Parker","year":"2014","journal-title":"J Clin Investig"},{"issue":"3","key":"10.1016\/j.acra.2025.07.034_bib12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","article-title":"The role of fibroblast activation protein in health and malignancy","volume":"39","author":"Fitzgerald","year":"2020","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"10.1016\/j.acra.2025.07.034_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s44303-024-00053-z","article-title":"Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)","volume":"2","author":"Mori","year":"2024","journal-title":"npj Imaging"},{"issue":"10","key":"10.1016\/j.acra.2025.07.034_bib14","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1007\/s00259-021-05660-1","article-title":"68 Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease","volume":"49","author":"Conen","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.acra.2025.07.034_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/s41181-024-00264-0","article-title":"99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications","volume":"9","author":"Boschi","year":"2024","journal-title":"EJNMMI Radiopharm Chem"},{"issue":"1","key":"10.1016\/j.acra.2025.07.034_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.acra.2024.07.032","article-title":"The role of FAPI PET imaging in pancreatic cancer: a meta-analysis compared with (18)F-FDG PET","volume":"32","author":"Hu","year":"2025","journal-title":"Acad Radiol"},{"issue":"1","key":"10.1016\/j.acra.2025.07.034_bib17","article-title":"Diagnostic and evaluative efficiency of 68Ga-FAPI-04 in skeletal muscle injury","volume":"14","author":"Wang","year":"2024","journal-title":"EJNMMI Res"},{"issue":"10","key":"10.1016\/j.acra.2025.07.034_bib18","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1016\/j.acra.2024.04.017","article-title":"PET imaging of fibroblast activation protein in various cancers using [(18)F]AlF\u2011NOTA\u2011FAPI\u201104: comparison with (18)F-FDG in a single-center, prospective study","volume":"31","author":"Yang","year":"2024","journal-title":"Acad Radiol"},{"issue":"12","key":"10.1016\/j.acra.2025.07.034_bib19","article-title":"FAPI PET\/CT imaging-an updated review","volume":"13","author":"Chandekar","year":"2023","journal-title":"Diagn (Basel)"},{"issue":"1","key":"10.1016\/j.acra.2025.07.034_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1148\/radiol.2021204677","article-title":"Simultaneous FAPI PET\/MRI targeting the fibroblast-activation protein for breast cancer","volume":"302","author":"Backhaus","year":"2021","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.acra.2025.07.034_bib21","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s11307-024-01928-8","article-title":"Volume-based quantitative measurement of [18F]AlF-NOTA-FAPI-04 PET\/CT uptake reflects the disease activity of IgG4-related disease","volume":"26","author":"Wan","year":"2024","journal-title":"Mol Imaging Biol"},{"issue":"February","key":"10.1016\/j.acra.2025.07.034_bib22","first-page":"1","article-title":"Iliopsoas fibrosis after revision of total hip arthroplasty revealed by 68Ga-FAPI PET\/CT: a case report","volume":"11","author":"Wang","year":"2024","journal-title":"Front Med"},{"key":"10.1016\/j.acra.2025.07.034_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1070973","article-title":"Post-myocardial infarction fibrosis: pathophysiology, examination, and intervention","volume":"14","author":"Yin","year":"2023","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.acra.2025.07.034_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12040297","article-title":"Extracellular matrix in heart disease: focus on circulating collagen type I and III derived peptides as biomarkers of myocardial fibrosis and their potential in the prognosis of heart failure: a concise review","volume":"12","author":"Nikolov","year":"2022","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.acra.2025.07.034_bib25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00259-022-05984-6","article-title":"Molecular imaging of fibroblast activity in pressure overload heart failure using [68 Ga] Ga-FAPI-04 PET\/CT","volume":"50","author":"Wang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"October","key":"10.1016\/j.acra.2025.07.034_bib26","first-page":"1","article-title":"Recent advances in positron emission tomography for detecting early fibrosis after myocardial infarction","volume":"11","author":"Wu","year":"2024","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.acra.2025.07.034_bib27","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00259-022-06015-0","article-title":"[68Ga] Ga-DOTA-FAPI-04 PET\/MR in patients with acute myocardial infarction: potential role of predicting left ventricular remodeling","volume":"50","author":"Zhang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.acra.2025.07.034_bib28","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/RLU.0000000000003745","article-title":"Visualization of fibroblast activation after myocardial infarction using 68Ga-FAPI PET","volume":"46","author":"Kessler","year":"2021","journal-title":"Clin Nucl Med"},{"issue":"8","key":"10.1016\/j.acra.2025.07.034_bib29","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1007\/s00259-021-05674-9","article-title":"Fibroblast activation protein imaging in reperfused ST-elevation myocardial infarction: comparison with cardiac magnetic resonance imaging","volume":"49","author":"Xie","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.acra.2025.07.034_bib30","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.121.263555","article-title":"Cardiac fibroblast activation in patients early after acute myocardial infarction: integration with MR tissue characterization and subsequent functional outcome","volume":"63","author":"Diekmann","year":"2022","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.acra.2025.07.034_bib31","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2967\/jnumed.121.262863","article-title":"Feasibility of in vivo imaging of fibroblast activation protein in human arterial walls","volume":"63","author":"Wu","year":"2022","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.acra.2025.07.034_bib32","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1007\/s00259-023-06245-w","article-title":"Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors","volume":"50","author":"Kosmala","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.acra.2025.07.034_bib33","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221052","article-title":"Myocardial activity at 18F-FAPI PET\/CT and risk for sudden cardiac death in hypertrophic cardiomyopathy","volume":"306","author":"Wang","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2025.07.034_bib34","first-page":"1","article-title":"Cardiac fibroblast activation in dilated cardiomyopathy detected by positron emission tomography","author":"Shi","year":"2022","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"10.1016\/j.acra.2025.07.034_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13550-023-00986-3","article-title":"Molecular imaging of fibroblast activation in multiple non-ischemic cardiomyopathies","volume":"13","author":"Wang","year":"2023","journal-title":"EJNMMI Res"},{"issue":"ement_1","key":"10.1016\/j.acra.2025.07.034_bib36","article-title":"Feasibility of 68Ga-FAPI-46 PET for evaluating fibrosis activity in aortic aneurysm","volume":"25","author":"Paeng","year":"2024","journal-title":"Eur Heart J - Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.acra.2025.07.034_bib37","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222389","article-title":"Evaluation of intestinal fibrosis with (68)Ga-FAPI PET\/MR enterography in crohn disease","volume":"307","author":"Scharitzer","year":"2023","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.acra.2025.07.034_bib38","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11604-024-01528-0","article-title":"Clinical value of [18F]AlF-NOTA-FAPI-04 PET\/CT for assessing early-stage liver fibrosis in adult liver transplantation recipients compared with chronic HBV patients","volume":"42","author":"Rao","year":"2024","journal-title":"Jpn J Radiol"},{"issue":"11","key":"10.1016\/j.acra.2025.07.034_bib39","first-page":"1960","article-title":"Feasibility of 68Ga-labeled fibroblast activation protein inhibitor PET\/CT in light-chain cardiac amyloidosis","volume":"15","author":"Wang","year":"2022","journal-title":"JACC: Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.acra.2025.07.034_bib40","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00259-024-06986-2","article-title":"Comparison of [18F] FAPI-42 and [18F] FDG PET\/CT in the evaluation of systemic vasculitis","volume":"52","author":"Zhong","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.acra.2025.07.034_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40336-022-00525-5","article-title":"Theranostic approach in liver cancer: an emerging paradigm to optimize personalized medicine","volume":"11","author":"Jokar","year":"2023","journal-title":"Clin Translat Imaging"},{"issue":"4","key":"10.1016\/j.acra.2025.07.034_bib42","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"issue":"0123456789","key":"10.1016\/j.acra.2025.07.034_bib43","article-title":"Efficacy of [68Ga]Ga-FAPI-PET as a non-invasive evaluation method of liver fibrosis","author":"Mori","year":"2025","journal-title":"Ann Nucl Med"},{"issue":"4","key":"10.1016\/j.acra.2025.07.034_bib44","first-page":"1","article-title":"18F]AlF-ND-bisFAPI PET imaging of fibroblast activation protein as a biomarker to monitor the progression of liver fibrosis","volume":"8","author":"Li","year":"2024","journal-title":"Hepatol Communic"},{"issue":"2","key":"10.1016\/j.acra.2025.07.034_bib45","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4274\/mirt.galenos.2022.80774","article-title":"68Ga-FAPI-04 PET\/CT findings in patients with liver cirrhosis","volume":"32","author":"Tatar","year":"2023","journal-title":"Mol Imaging Radionucl Ther"},{"key":"10.1016\/j.acra.2025.07.034_bib46","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11604-024-01528-0","article-title":"Clinical value of [18F]AlF-NOTA-FAPI-04 PET\/CT for assessing early-stage liver fibrosis in adult liver transplantation recipients compared with chronic HBV patients","author":"Rao","year":"2024","journal-title":"Jpn J Radiol"},{"issue":"12","key":"10.1016\/j.acra.2025.07.034_bib47","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1007\/s00259-024-06773-z","article-title":"Non-invasive visualization of liver fibrosis with [68Ga]Ga-DOTA-FAPI-04 PET from preclinical insights to clinical translation","volume":"51","author":"Song","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.acra.2025.07.034_bib48","first-page":"1","article-title":"Diagnosis and management of interstitial lung disease","volume":"2","author":"Meyer","year":"2014","journal-title":"Translat Respir Med"},{"issue":"6","key":"10.1016\/j.acra.2025.07.034_bib49","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/resp.12531","article-title":"HRCT of fibrosing lung disease","volume":"20","author":"Jacob","year":"2015","journal-title":"Respirology"},{"issue":"3","key":"10.1016\/j.acra.2025.07.034_bib50","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.humpath.2005.11.020","article-title":"Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis","volume":"37","author":"Acharya","year":"2006","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.acra.2025.07.034_bib51","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1164\/rccm.202110-2414OC","article-title":"Comprehensive analysis of fibroblast activation protein expression in interstitial lung diseases","volume":"207","author":"Yang","year":"2023","journal-title":"Am J Respir Critic Care Med"},{"key":"10.1016\/j.acra.2025.07.034_bib52","doi-asserted-by":"crossref","unstructured":"Liu C., Guo Z., Shi Y., et al. 18 F-FAPI PET\/CT Imaging in Pneumoconiosis: a new tool for early diagnosis and guiding treatment of pulmonary fibrosis. 2025. p. 1\u201324.","DOI":"10.1101\/2025.03.29.25324444"},{"issue":"1","key":"10.1016\/j.acra.2025.07.034_bib53","first-page":"e17","article-title":"Exploring the potential value of [68Ga] Ga-FAPI-46 PET\/CT for molecular assessment of fibroblast activation in interstitial lung disease: a single-center pilot study","volume":"50","author":"Bahtouee","year":"2025","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.acra.2025.07.034_bib54","first-page":"1","article-title":"Initial results with [18F] FAPI-74 PET\/CT in idiopathic pulmonary fibrosis","author":"Mori","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.acra.2025.07.034_bib55","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.3390\/ph16101434","article-title":"99mTc-labeled FAPI SPECT imaging in idiopathic pulmonary fibrosis: preliminary results","volume":"16","author":"Liu","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.acra.2025.07.034_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eclinm.2024.102598","article-title":"FAPi PET\/CT for assessment and visualisation of active myositis-related interstitial lung disease: a prospective observational pilot study","volume":"72","author":"Kastrati","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"486","key":"10.1016\/j.acra.2025.07.034_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat4865","article-title":"Elastin imaging enables noninvasive staging and treatment monitoring of kidney fibrosis","volume":"11","author":"Sun","year":"2019","journal-title":"Sci Translat Med"},{"issue":"9","key":"10.1016\/j.acra.2025.07.034_bib58","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1681\/ASN.2016101089","article-title":"Magnetic resonance imaging of the fibrotic kidney","volume":"28","author":"Morrell","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.acra.2025.07.034_bib59","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2967\/jnumed.123.265640","article-title":"68Ga]Ga-FAPI-46 PET for visualization of postinfarction renal fibrosis","volume":"64","author":"Unterrainer","year":"2023","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.acra.2025.07.034_bib60","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2967\/jnumed.124.268643","article-title":"68Ga-FAPI-04 PET\/CT imaging for assessing renal tubulointerstitial fibrosis in lupus nephritis","volume":"66","author":"Yu","year":"2025","journal-title":"J Nucl Med: official publication, Society of Nuclear Medicine"},{"issue":"12","key":"10.1016\/j.acra.2025.07.034_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ckj\/sfae340","article-title":"Non-invasive assessment of IgA nephropathy severity with [18F]AlF-NOTA-FAPI-04 PET\/CT imaging","volume":"17","author":"Wang","year":"2024","journal-title":"Clin Kidney J"},{"issue":"5","key":"10.1016\/j.acra.2025.07.034_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ckj\/sfae064","article-title":"18F] AlF-NOTA-FAPI-04 PET\/CT for non-invasive assessment of tubular injury in kidney diseases","volume":"17","author":"Wang","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.acra.2025.07.034_bib63","article-title":"Recent advances in nuclear medicine and their role in inflammatory arthritis: focus on the emerging role of FAPI PET\/CT","volume":"0123456789","author":"Schmidkonz","year":"2024","journal-title":"Skelet Radiol"},{"issue":"3","key":"10.1016\/j.acra.2025.07.034_bib64","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222052","article-title":"68Ga-FAPI PET\/CT for rheumatoid arthritis: a prospective study","volume":"307","author":"Luo","year":"2023","journal-title":"Radiology"},{"issue":"18","key":"10.1016\/j.acra.2025.07.034_bib65","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.7150\/thno.102627","article-title":"Dual targeting heterodimer PET tracer [18F]AlF\u2011FAPI\u2011RGD in patients with rheumatoid arthritis: a pilot exploratory study","volume":"14","author":"Wang","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.acra.2025.07.034_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118048","article-title":"Feasibility assessment of radiolabeled FAPI-04 for diagnostic and therapeutic use in rheumatoid arthritis","volume":"187","author":"Tseng","year":"2025","journal-title":"Biomed Pharmacother"},{"issue":"October","key":"10.1016\/j.acra.2025.07.034_bib67","first-page":"1","article-title":"68Ga-FAPI and 18F-NaF PET\/CT in psoriatic arthritis: a comparative study","author":"Yang","year":"2024","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.acra.2025.07.034_bib68","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004294","article-title":"Anatomical pattern of entheseal and synovial fibroblast activation in patients with psoriasis and its risk of developing psoriatic arthritis","volume":"10","author":"Corte","year":"2024","journal-title":"RMD Open"},{"issue":"7","key":"10.1016\/j.acra.2025.07.034_bib69","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00259-023-06146-y","article-title":"Diagnostic efficiency of [68 Ga]Ga-DOTA-FAPI-04 in differentiating periprosthetic hip joint infection and aseptic failure","volume":"50","author":"Wang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.acra.2025.07.034_bib70","first-page":"1","article-title":"18F-FDG and 68 Ga-FAPI PET\/CT for the evaluation of periprosthetic joint infection and aseptic loosening in rabbit models","volume":"23","author":"Wang","year":"2022","journal-title":"BMC Musculoskelet Disord"},{"issue":"3","key":"10.1016\/j.acra.2025.07.034_bib71","article-title":"Different uptake patterns of 68Ga-FAPI in aseptic loosening and periprosthetic joint infection of hip arthroplasty: A case series and literature review","volume":"9","author":"Wang","year":"2022","journal-title":"Front Med"},{"issue":"7","key":"10.1016\/j.acra.2025.07.034_bib72","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1007\/s00259-023-06179-3","article-title":"FAPI PET\/CT in infectious, inflammatory, and rheumatological diseases: \u201cwatch it like a hawk\u201d or \u201cone swallow does not make a summer\u201d?","volume":"50","author":"Treglia","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.acra.2025.07.034_bib73","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/RLU.0000000000003798","article-title":"Increased 68Ga-FAPI uptake in ankylosing spondylitis in a patient with rectal cancer","volume":"47","author":"Yao","year":"2022","journal-title":"Clin Nucl Med"},{"issue":"9","key":"10.1016\/j.acra.2025.07.034_bib74","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/RLU.0000000000003671","article-title":"Fibrous dysplasia mimicking skeletal metastasis on 68Ga-FAPI PET imaging","volume":"46","author":"Song","year":"2021","journal-title":"Clin Nucl Med"},{"issue":"4","key":"10.1016\/j.acra.2025.07.034_bib75","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/RLU.0000000000003990","article-title":"Bone tuberculous granulomatous inflammation mimicking malignancy on 68Ga-FAPI PET\/CT","volume":"47","author":"Gong","year":"2022","journal-title":"Clin Nucl Med"},{"issue":"7","key":"10.1016\/j.acra.2025.07.034_bib76","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/MNM.0000000000001563","article-title":"Physiological tracer distribution and benign lesion incidental uptake of Al18F-NOTA-FAPI-04 on PET\/CT imaging","volume":"43","author":"Kou","year":"2022","journal-title":"Nucl Med Commun"},{"issue":"3","key":"10.1016\/j.acra.2025.07.034_bib77","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/RLU.0000000000003491","article-title":"68Ga-DOTA-FAPI-04 PET\/CT in Erdheim-Chester disease","volume":"46","author":"Wu","year":"2021","journal-title":"Clin Nucl Med"},{"issue":"7","key":"10.1016\/j.acra.2025.07.034_bib78","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/RLU.0000000000004213","article-title":"Intense 68Ga-FAPI uptake in a patient with myositis ossificans: mimicking bone malignancy","volume":"47","author":"Gong","year":"2022","journal-title":"Clin Nucl Med"},{"issue":"15","key":"10.1016\/j.acra.2025.07.034_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11154514","article-title":"Emerging role of FAPI PET imaging for the assessment of benign bone and joint diseases","volume":"11","author":"Dondi","year":"2022","journal-title":"J of Clin Med"},{"issue":"4","key":"10.1016\/j.acra.2025.07.034_bib80","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/biomedicines13040775","article-title":"FAPi PET\/CT imaging to identify fibrosis in immune-mediated inflammatory diseases","volume":"13","author":"Lartey","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.acra.2025.07.034_bib81","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1007\/s10067-024-07155-4","article-title":"Head to head comparison of 18F-FDG and Al18F-NOTA-FAPI-04 PET\/CT imaging used in diagnosis of autoimmune rheumatic diseases","volume":"52","author":"Li","year":"2024","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.acra.2025.07.034_bib82","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s00259-023-06107-5","article-title":"68Ga]Ga-FAPI-04 PET\/CT on assessing Crohn\u2019s disease intestinal lesions","volume":"50","author":"Chen","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.acra.2025.07.034_bib83","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/1756-185X.12586","article-title":"IgG4-related disease","volume":"19","author":"Kubo","year":"2016","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"10.1016\/j.acra.2025.07.034_bib84","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2967\/jnumed.120.244723","article-title":"Fibroblast activation protein-targeted PET\/CT with 68Ga-FAPI for imaging igg4-related disease: comparison to 18F-FDG PET\/CT","volume":"62","author":"Luo","year":"2021","journal-title":"J of Nucl Med"},{"issue":"4","key":"10.1016\/j.acra.2025.07.034_bib85","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/RLU.0000000000005504","article-title":"Negative 18 F-FDG and positive 68 Ga-FAPI-04 findings in a patient with acute exacerbation of chronic cholecystitis","volume":"50","author":"Qi","year":"2025","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.acra.2025.07.034_bib86","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13550-024-01129-y","article-title":"68)Ga]Ga-FAPI versus 2-[(18)F]FDG PET\/CT in patients with autoimmune thyroiditis: a case control study","volume":"14","author":"Pabst","year":"2024","journal-title":"EJNMMI Res"},{"issue":"8","key":"10.1016\/j.acra.2025.07.034_bib87","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3390\/diagnostics13081450","article-title":"In vivo fibroblast activation of systemic sarcoidosis: a 68Ga-FAPI-04 PET\/CT imaging study","volume":"13","author":"Wang","year":"2023","journal-title":"Diagnostics"},{"issue":"8","key":"10.1016\/j.acra.2025.07.034_bib88","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/qjmed\/hcae067","article-title":"Fibroblast activation in sarcoidosis as assessed by 68Ga-FAPI (fibroblast activation protein inhibitor)-46 PET\/CT","volume":"117","author":"O'Brien","year":"2024","journal-title":"QJM"},{"issue":"5","key":"10.1016\/j.acra.2025.07.034_bib89","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/RLU.0000000000005120","article-title":"Application value of 68 Ga-FAPI PET\/CT in the evaluation of myelofibrotic diseases","volume":"49","author":"Liu","year":"2024","journal-title":"Clin Nucl Med"},{"issue":"7","key":"10.1016\/j.acra.2025.07.034_bib90","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1007\/s00259-024-06644-7","article-title":"Comparative analysis of [(18)F]F-FAPI PET\/CT, [(18)F]F-FDG PET\/CT and magnetization transfer MR imaging to detect intestinal fibrosis in Crohn's disease: A prospective animal model and human cohort study","volume":"51","author":"Li","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.acra.2025.07.034_bib91","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1053\/j.semnuclmed.2024.02.006","article-title":"FAPI-PET in cardiovascular disease","volume":"54","author":"Higuchi","year":"2024","journal-title":"Semin Nucl Med"},{"issue":"8","key":"10.1016\/j.acra.2025.07.034_bib92","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1021\/acs.molpharmaceut.3c00452","article-title":"Potential value of FAPI PET\/CT in the detection and treatment of fibrosing mediastinitis: preclinical and pilot clinical investigation","volume":"20","author":"Song","year":"2023","journal-title":"Mol Pharm"},{"issue":"11","key":"10.1016\/j.acra.2025.07.034_bib93","doi-asserted-by":"crossref","DOI":"10.1097\/RLU.0000000000003810","article-title":"Feasibility and therapeutic potential of 177Lu\u2013fibroblast activation protein inhibitor\u201346 for patients with relapsed or refractory cancers: a preliminary study","volume":"46","author":"Assadi","year":"2021","journal-title":"Clin Nucl Med"},{"issue":"3","key":"10.1016\/j.acra.2025.07.034_bib94","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40336-023-00609-w","article-title":"Exploring the efficacy of FAPI PET\/CT in the diagnosis and treatment management of colorectal cancer: a comprehensive literature review and initial experience","volume":"12","author":"Dadgar","year":"2024","journal-title":"Clin Translat Imaging"},{"issue":"1","key":"10.1016\/j.acra.2025.07.034_bib95","article-title":"Non-specific uptake of 18F-FAPI-04 in the pancreas and its related factors: a post-hoc analysis of an ongoing prospective clinical trial","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633225007044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633225007044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T21:01:02Z","timestamp":1763326862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633225007044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":95,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1076633225007044"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2025.07.034","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond Cancer: The Role of Radiolabeled Fibroblast Activation Protein Inhibitors (FAPI) in Non-Oncological Molecular Imaging","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2025.07.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Association of Academic Radiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}